Clinical Applications of Hyaluronidase
- PMID: 31482503
- DOI: 10.1007/978-981-13-7709-9_12
Clinical Applications of Hyaluronidase
Abstract
Hyaluronidases are enzymes that degrade hyaluronic acid, which constitutes an essential part of the extracellular matrix. Initially discovered in bacteria, hyaluronidases are known to be widely distributed in nature and have been found in many classes including insects, snakes, fish and mammals. In the human, six different hyaluronidases, HYAL1-4, HYAL-P1 and PH-20, have been identified. PH-20 exerts the strongest biologic activity, is found in high concentrations in the testicles and can be localized on the head and the acrosome of human spermatozoa. Today, animal-derived bovine or ovine testicular hyaluronidases as well as synthetic hyaluronidases are clinically applied as adjuncts to increase the bioavailability of drugs, for the therapy of extravasations, or for the management of complications associated with the aesthetic injection of hyaluronic acid-based fillers. Further applications in the fields of surgery, aesthetic medicine, immunology, oncology, and many others can be expected for years to come. Here, we give an overview over the molecular and cellular mode of action of hyaluronidase and the hyaluronic acid metabolism, as well as over current and potential future clinical applications of hyaluronidase.
Keywords: Bioavailability; Extravasation; Filler; Hyaluronan; Hyaluronic acid; Hylase; Spreading factor.
Similar articles
-
Isoenzyme-specific differences in the degradation of hyaluronic acid by mammalian-type hyaluronidases.Glycoconj J. 2008 Feb;25(2):101-9. doi: 10.1007/s10719-007-9058-8. Epub 2007 Jul 10. Glycoconj J. 2008. PMID: 17620008
-
Hyaluronidases--a group of neglected enzymes.Protein Sci. 1995 Sep;4(9):1666-9. doi: 10.1002/pro.5560040902. Protein Sci. 1995. PMID: 8528065 Free PMC article. Review.
-
Effect of depletion of interstitial hyaluronan on hydraulic conductance in rabbit knee synovium.J Physiol. 1998 Jun 15;509 ( Pt 3)(Pt 3):695-710. doi: 10.1111/j.1469-7793.1998.695bm.x. J Physiol. 1998. PMID: 9596792 Free PMC article.
-
The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers.Aesthet Surg J. 2013 Nov 1;33(8):1167-74. doi: 10.1177/1090820X13511970. Epub 2013 Nov 6. Aesthet Surg J. 2013. PMID: 24197934 Review.
-
Dose- and time-dependent effects of hyaluronidase on structural cells and the extracellular matrix of the skin.Eur J Med Res. 2020 Nov 23;25(1):60. doi: 10.1186/s40001-020-00460-z. Eur J Med Res. 2020. PMID: 33228813 Free PMC article.
Cited by
-
Modulation of hyaluronan signaling as a therapeutic target in human disease.Pharmacol Ther. 2022 Apr;232:107993. doi: 10.1016/j.pharmthera.2021.107993. Epub 2021 Sep 26. Pharmacol Ther. 2022. PMID: 34587477 Free PMC article. Review.
-
A nonsynonymous polymorphism (rs117179004, T392M) of hyaluronidase 1 (HYAL1) is associated with increased risk of idiopathic pulmonary fibrosis in Southern Han Chinese.J Clin Lab Anal. 2021 Jun;35(6):e23782. doi: 10.1002/jcla.23782. Epub 2021 May 4. J Clin Lab Anal. 2021. PMID: 33942374 Free PMC article.
-
Recent Advancements in Nanomedicine for 'Cold' Tumor Immunotherapy.Nanomicro Lett. 2021 Mar 16;13(1):92. doi: 10.1007/s40820-021-00622-6. Nanomicro Lett. 2021. PMID: 34138315 Free PMC article. Review.
-
Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.J Nanobiotechnology. 2021 Nov 22;19(1):384. doi: 10.1186/s12951-021-01134-6. J Nanobiotechnology. 2021. PMID: 34809634 Free PMC article. Review.
-
Substitution of acidic residues near the catalytic Glu131 leads to human HYAL1 activity at neutral pH via charge-charge interactions.PLoS One. 2024 Aug 9;19(8):e0308370. doi: 10.1371/journal.pone.0308370. eCollection 2024. PLoS One. 2024. PMID: 39121049 Free PMC article.
References
-
- Ahmed S, Ahmed OA (2004) Hyaluronidase revisited-a single injection technique for harvesting split thickness skin grafts under local anaesthesia. Br J Plast Surg 57:589–591 - PubMed
-
- Albanell J, Baselga J (2000) Systemic therapy emergencies. Semin Oncol 27:347–361 - PubMed
-
- Alberts DS, Dorr RT (1991) Case report: topical DMSO for mitomycin-C-induced skin ulceration. Oncol Nurs Forum 18:693–695 - PubMed
-
- Allen CH, Etzwiler LS, Miller MK et al (2009) Recombinant human hyaluronidase-enabled subcutaneous pediatric rehydration. Pediatrics 124:e858–e867 - PubMed
-
- Aruffo A, Stamenkovic I, Melnick M et al (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303–1313 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources